Have World COPD Day news, a statement or an event? Send it to us — we cover it here.
The Week in Respiratory Health
The week's most important lung-health stories in one short email, every Friday. Free; unsubscribe any time. Also in Español, Français, Português and Русский.
Prof Chris P Gale said a meta-analysis of 140 case-control studies found COPD was associated with higher risks of heart failure, heart attack, chronic kidney disease and death.
Pooled data from two randomised trials presented at ERS 2026 point to fewer flu and pneumonia hospitalisations with high-dose vaccine in adults aged 65 and over with lung disease.
A post from ERS publications says biomarker patterns differ across diagnostic groups, sometimes in opposite directions, suggesting distinct underlying mechanisms.
Leicester researchers said the final participant in the MINT-COPD trial of RJx-01 for people hospitalised with severe COPD flare-ups was seen this week.
In a post on X, the critical care physician outlined how dynamic hyperinflation and auto-PEEP arise, how they are identified on the ventilator, and how they can be managed.
A study of 5,634 patients in China found lower temperatures and extreme cold events, especially compound cold spells, were associated with acute exacerbations of COPD, while higher temperatures were not.
The Lawyers' Committee for Civil Rights Under Law said race-based adjustments in lung function tests may affect how veterans' respiratory disabilities are assessed and compensated.
A Financial News Health Talk item says national screenings to detect COPD will begin this year, with a headline referring to a single breath test revealing 'lung age'.
Writing on X after World Pneumonia Day, the WHO technical officer cited 2.5 million pneumonia deaths in 2023 and said prevention belongs within routine NCD care.
A European Medical Journal post says blocking IL-33 lowered moderate-to-severe COPD flare rates versus placebo over 52 weeks in 1,750 patients on inhaled maintenance therapy.
In a critical physiology series post on X, the Venezuelan critical care physician set out the mechanisms, diagnosis and management of acute hypercapnic respiratory failure.
A Research Letter in the journal CHEST assessed recruitment centre locations and eligibility criteria in phase III/IV trials of single-inhaler triple therapy and biologics for COPD.
A post from ERS publications reports that increased use of SAMA, or SABA plus SAMA, was associated with higher cardiovascular and mortality risks in people with asthma and COPD.
A modelling study of 136 low- and middle-income countries estimates large health and economic gains if air pollution met WHO guideline levels, according to a post by Dr Alexey Kulikov.
A systematic review of 26 studies and 43,051 patients found COPD associated with higher odds of postoperative delirium, though the evidence is largely observational and heterogeneous.
Pulse Today reports that GPs will receive £40m this winter to support patients with frailty, heart disease and chronic obstructive pulmonary disease (COPD).
Prof Chris P Gale reported that 56.6% of 70,034 people with new COPD had a cardiopulmonary event in the three years before diagnosis, versus 20.9% of controls.
A post on X summarising new research says the standard could achieve 83% of WHO's 2040 air pollution mortality target, with the largest gains in COPD, stroke and lung cancer.
A cross-sectional study reports an association between a symptom phenotype dominated by sinonasal symptoms and exacerbations of COPD, according to a post from Respirology.
An update from the Lancet Commission on COPD reviews progress since 2022 and proposes a framework spanning lung development, ageing, precision medicine, patient-centred outcomes and regulatory reform.
A retrospective study of nearly 1,500 spirometry tests looked at whether patients and pulmonary function technicians speaking different languages affected test quality, according to Respiratory Care.
An abstract by Sullivan et al. found people with rheumatoid arthritis, particularly those with COPD, had a higher exacerbation risk than those without the condition, according to a rheumatologist's post.
A post from the ATS Blue Journal account highlights a GOLD Science Committee perspective on exacerbations and cardiovascular risk in chronic obstructive pulmonary disease.
Editor in Chief Dr Peter Mazzone highlights studies in the November 2026 issue of the journal CHEST, according to a post from the official CHEST account on X.
The critical care physician wrote on X that new CHEST guidance on inpatient tobacco use management strongly recommends starting varenicline in hospital, and asked colleagues whether they already do so.
The UN Task Force on NCDs official wrote on X that PM2.5 exceeded 461 µg/m³ in parts of the city despite tighter traffic and construction restrictions.
Yahoo Finance Singapore reports that Merck has started a COPD trial named ENHANCE 3, at a time when a review of one of its cancer drugs is approaching.
The pulmonologist shared a thread summarising a CME symposium on bronchiectasis diagnosis, disease heterogeneity and emerging therapeutic strategies, held at GOLDCOPD2026.
The American College of Chest Physicians highlighted original research on the content and design of inhaler conversation aids for asthma and COPD in the November issue of CHEST.
UK Politics Decoded reported that up to 300,000 patients with heart disease, frailty or COPD could receive medication reviews, health checks and other proactive support.
Nick Hopkinson shared an editorial on X arguing that big tobacco is shifting to big addiction and must be curbed, tagging The BMJ, ASH and the FCTC account.
The Oxford professor said two major bronchiectasis talks were held at the GOLD COPD conference, and that patients will benefit from early diagnosis and proper treatment.
The Oxford professor and European Respiratory Journal chief editor described an 'ABC team' of asthma, bronchiectasis and COPD in a post on X, naming colleagues linked to GOLD, GINA and EMBARC.
The American College of Chest Physicians highlighted a Research Letter on delivering pulmonary rehabilitation remotely to people with COPD who live in rural areas.
HCPLive posted on X about an interview with Dave Singh, MD, asking whether biologics for COPD are moving beyond eosinophils and who is likely to respond.
A study of New York City Fire Department workers exposed to the World Trade Center site reports that oscillometry detects a symptomatic phenotype that spirometry misses.
A Chest cohort study of 47,583 patients found modest shifts towards LAMA and away from ICS/LABA after British Columbia changed drug coverage rules in July 2020.
Researchers developed a points-based score for people without airflow obstruction and validated it in two further cohorts, with higher scores linked to greater risk of developing COPD.